{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-07T07:42:57.189587+00:00","published_at":"2026-10-07T06:08:55.166756+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v1","events":[{"event_id":"alpha:event:executive_appointed:5o5ezt","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-09","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","alpha:person:christopher-volker"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:fa3d03479f67526dbfb191bd6594ee3c651be55e779a14cf0b1a446437666b77"],"summary":"Christopher Volker executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:ceo_changed:khxq49","event_type":"CEO_CHANGED","effective_at":"2026-03-09","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","alpha:person:david-rosa-2"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:c0c9b18682644ebd0b789867ef7b763e1e24fb7e8df6042dbbcb2aa6d4b17fc3"],"summary":"David Rosa executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:gc_changed:1wzsi3v","event_type":"GC_CHANGED","effective_at":"2026-03-09","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","alpha:person:emily-johns"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:7b017bda293042dfc4e425b31f32c9580f4991668e3c2353be9fb4efe129ab81"],"summary":"Emily Johns executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:cfo_changed:1eud09b","event_type":"CFO_CHANGED","effective_at":"2026-03-09","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","alpha:person:ronald-mcclurg"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:fccf7707d9cd6205c6f9912f064096b8e0707642a76537cae4c774b7786ec683"],"summary":"Ronald McClurg executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:executive_appointed:1ljrlt6","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-09","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","alpha:person:steve-mertens"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:c5a8c9faf61eecdf5877adbf8ed97157e1dfe4d7dcb979c428c55fda2753ef29"],"summary":"Steve Mertens executive of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2026-03-09.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:ddjg39","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","alpha:person:jason-mills"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Jason Mills seat on NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_created:ya3p78","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:committee:neuroone-medical-technologies-corp:compensation-nominating-and-governance","alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Compensation; Nominating and Governance committee of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_member_added:5z9eo2","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:committee:neuroone-medical-technologies-corp:compensation-nominating-and-governance","alpha:person:jason-mills"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Jason Mills member of Compensation; Nominating and Governance, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:gzaywe","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","alpha:person:edward-andrle"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Edward Andrle seat on NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_created:1b6dlpz","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:committee:neuroone-medical-technologies-corp:audit-nominating-and-governance-chair","alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Audit; Nominating and Governance · Chair committee of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_member_added:1he5b4d","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:committee:neuroone-medical-technologies-corp:audit-nominating-and-governance-chair","alpha:person:edward-andrle"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Edward Andrle member of Audit; Nominating and Governance · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:eyr8w2","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","alpha:person:david-rosa-2"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"David Rosa seat on NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:s5l84i","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","alpha:person:jeffrey-mathiesen"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Jeffrey S. Mathiesen seat on NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:1gu3yrj","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","alpha:person:paul-buckman"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Paul Buckman seat on NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_created:1yevlbu","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:committee:neuroone-medical-technologies-corp:audit-chair-compensation-nominating-and-governance","alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Audit · Chair; Compensation; Nominating and Governance committee of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_member_added:1xhwpjt","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:committee:neuroone-medical-technologies-corp:audit-chair-compensation-nominating-and-governance","alpha:person:jeffrey-mathiesen"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Jeffrey S. Mathiesen member of Audit · Chair; Compensation; Nominating and Governance, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_created:52c4h9","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:committee:neuroone-medical-technologies-corp:audit-compensation-chair","alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Audit; Compensation · Chair committee of NEUROONE MEDICAL TECHNOLOGIES Corp, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_member_added:19yrl80","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-07T06:08:55.166756+00:00","subject_ids":["alpha:committee:neuroone-medical-technologies-corp:audit-compensation-chair","alpha:person:paul-buckman"],"caused_claim_ids":["alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b"],"summary":"Paul Buckman member of Audit; Compensation · Chair, effective 2017-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:5","subject_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-rosa-2","object_label":"David Rosa","object_source_name_forms":[],"value":"David Rosa: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-rosa-2","name":"David Rosa"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-07T06:08:55.166756+00:00","sources":[{"id":"alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"NEUROONE MEDICAL TECHNOLOGIES Corp DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:25:01.166+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:6","subject_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:edward-andrle","object_label":"Edward Andrle","object_source_name_forms":[],"value":"Edward Andrle: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:edward-andrle","name":"Edward Andrle"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-07T06:08:55.166756+00:00","sources":[{"id":"alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"NEUROONE MEDICAL TECHNOLOGIES Corp DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:25:01.166+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:7","subject_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jason-mills","object_label":"Jason Mills","object_source_name_forms":[],"value":"Jason Mills: Director, Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jason-mills","name":"Jason Mills"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-07T06:08:55.166756+00:00","sources":[{"id":"alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"NEUROONE MEDICAL TECHNOLOGIES Corp DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:25:01.166+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:8","subject_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jeffrey-mathiesen","object_label":"Jeffrey S. Mathiesen","object_source_name_forms":[],"value":"Jeffrey S. Mathiesen: Director, Audit · Chair; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jeffrey-mathiesen","name":"Jeffrey S. Mathiesen"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-07T06:08:55.166756+00:00","sources":[{"id":"alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"NEUROONE MEDICAL TECHNOLOGIES Corp DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:25:01.166+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:9","subject_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:paul-buckman","object_label":"Paul Buckman","object_source_name_forms":[],"value":"Paul Buckman: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:paul-buckman","name":"Paul Buckman"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-07T06:08:55.166756+00:00","sources":[{"id":"alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"NEUROONE MEDICAL TECHNOLOGIES Corp DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:25:01.166+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:10","subject_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christopher-volker","object_label":"Christopher Volker","object_source_name_forms":[],"value":"Christopher Volker: Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christopher-volker","name":"Christopher Volker"},"title":"Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-07T06:08:55.166756+00:00","sources":[{"id":"alpha:projection-evidence:document:fa3d03479f67526dbfb191bd6594ee3c651be55e779a14cf0b1a446437666b77","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NMTC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T06:00:59.886422+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:11","subject_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:david-rosa-2","object_label":"David Rosa","object_source_name_forms":[],"value":"David Rosa: Chief Executive Officer, President and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:david-rosa-2","name":"David Rosa"},"title":"Chief Executive Officer, President and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-07T06:08:55.166756+00:00","sources":[{"id":"alpha:projection-evidence:document:c0c9b18682644ebd0b789867ef7b763e1e24fb7e8df6042dbbcb2aa6d4b17fc3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NMTC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T06:00:58.998305+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:12","subject_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:emily-johns","object_label":"Emily Johns","object_source_name_forms":[],"value":"Emily Johns: Chief Administrative Officer, General Counsel","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:emily-johns","name":"Emily Johns"},"title":"Chief Administrative Officer, General Counsel","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-07T06:08:55.166756+00:00","sources":[{"id":"alpha:projection-evidence:document:7b017bda293042dfc4e425b31f32c9580f4991668e3c2353be9fb4efe129ab81","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NMTC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T06:01:01.643584+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:13","subject_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:ronald-mcclurg","object_label":"Ronald McClurg","object_source_name_forms":[],"value":"Ronald McClurg: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:ronald-mcclurg","name":"Ronald McClurg"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-07T06:08:55.166756+00:00","sources":[{"id":"alpha:projection-evidence:document:fccf7707d9cd6205c6f9912f064096b8e0707642a76537cae4c774b7786ec683","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NMTC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T06:00:59.372736+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:3881290c-ddb4-45a3-98f3-c14abafd383e:leadership_role:14","subject_id":"alpha:company:3881290c-ddb4-45a3-98f3-c14abafd383e","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:steve-mertens","object_label":"Steve Mertens","object_source_name_forms":[],"value":"Steve Mertens: Chief Technology Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:steve-mertens","name":"Steve Mertens"},"title":"Chief Technology Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-07T06:08:55.166756+00:00","sources":[{"id":"alpha:projection-evidence:document:c5a8c9faf61eecdf5877adbf8ed97157e1dfe4d7dcb979c428c55fda2753ef29","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NMTC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T06:01:00.581616+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:58a0c6a2787892622e3bbce779638958e7a9af462053500f028a6f057516a82b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"NEUROONE MEDICAL TECHNOLOGIES Corp DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:25:01.166+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:fa3d03479f67526dbfb191bd6594ee3c651be55e779a14cf0b1a446437666b77","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NMTC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T06:00:59.886422+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c0c9b18682644ebd0b789867ef7b763e1e24fb7e8df6042dbbcb2aa6d4b17fc3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NMTC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T06:00:58.998305+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7b017bda293042dfc4e425b31f32c9580f4991668e3c2353be9fb4efe129ab81","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NMTC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T06:01:01.643584+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:fccf7707d9cd6205c6f9912f064096b8e0707642a76537cae4c774b7786ec683","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NMTC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T06:00:59.372736+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c5a8c9faf61eecdf5877adbf8ed97157e1dfe4d7dcb979c428c55fda2753ef29","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NMTC DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026024927/ea0277882-02.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T06:01:00.581616+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.836,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.9,"cross_source_agreement":0.75,"temporal_completeness":0.526},"diagnostics":{"published_claims":26,"factual_claims":26,"claims_with_linked_evidence":26,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":19,"temporal_claims_with_valid_from":10,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-07T06:08:55.166756+00:00","observed_at":"2026-10-07T06:08:55.166756+00:00","reviewed_at":"2026-10-07T06:08:55.166756+00:00","verified_at":"2026-10-07T06:08:55.166756+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/neuroone-medical-technologies-corp/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/neuroone-medical-technologies-corp?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}